The site will be unavailable in 41 minutes for scheduled maintenance.

$7.43 -0.22 (-2.88%)
2/10/2012 4:00 PM

Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Featured Broker Partners


Advertisement